This compound is a triazolopyridine derivative that serves as a pharmaceutical intermediate in the manufacturing process of Tucatinib. It is characterized by a fused ring system containing both triazole and pyridine moieties, with a ketone functional group contributing to its moderate polarity.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1033810-70-6
1-((2S)-pyrrolidin-2-yl)methanamine dihydrochloride
pharmaceutical intermediate
4-Amino-1-[3,5-bis-O-(4-chlorobenzoyl)-2-deoxy-beta-D-erythro-pentofuranosyl]-1,3,5-triazin-2(1H)-one
decitabine intermediate for pharmaceutical synthesis
2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene
Pharmaceutical intermediate
(2S)-1-[(tert-butoxy)carbonyl]-4-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperazine-2-carboxylic acid
Pharmaceutical intermediate with protecting groups
3H-[1,2,4]triazolo[1,5-a]pyridin-7-one
BABOSZMRHSQJCE-UHFFFAOYSA-N
C1=CN2C(=CC1=O)N=CN2
—